Literature DB >> 28737280

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib.

Benjamin Andrick1,2, Abdulrahman Alwhaibi2, David L DeRemer1,2,3, Sameera Quershi3, Rahil Khan3, Locke J Bryan1,3,4, Payaningal R Somanath2,3,5, Jeremy Pantin1,3,4.   

Abstract

Entities:  

Keywords:  chronic lymphocytic leukaemia; ibrutinib; infection; pneumococcal

Mesh：

Substances：

Year:  2017        PMID： 28737280     DOI： 10.1111/bjh.14855

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

1.  Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL).

Authors:  Francesca Romana Mauro; Diana Giannarelli; Clementina Maria Galluzzo; Candida Vitale; Andrea Visentin; Costantino Riemma; Serena Rosati; Marika Porrazzo; Sara Pepe; Marta Coscia; Livio Trentin; Massimo Gentile; Sara Raponi; Alessandra Micozzi; Giuseppe Gentile; Silvia Baroncelli
Journal:  Leukemia       Date:  2020-06-17       Impact factor: 11.528

Review 2.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

3.  Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.

Authors:  H Parry; G McIlroy; R Bruton; M Ali; C Stephens; S Damery; A Otter; T McSkeane; H Rolfe; S Faustini; N Wall; P Hillmen; G Pratt; S Paneesha; J Zuo; A Richter; P Moss
Journal:  Blood Cancer J       Date:  2021-07-30       Impact factor: 11.037

Review 4.  Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Authors:  Georg Maschmeyer; Julien De Greef; Sibylle C Mellinghoff; Annamaria Nosari; Anne Thiebaut-Bertrand; Anne Bergeron; Tomas Franquet; Nicole M A Blijlevens; Johan A Maertens
Journal:  Leukemia       Date:  2019-01-30       Impact factor: 11.528

Review 5.  Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.

Authors:  Petra Langerbeins; Barbara Eichhorst
Journal:  Acta Haematol       Date:  2021-02-25       Impact factor: 2.195

6.  Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.

Authors:  Maria Gavriatopoulou; Evangelos Terpos; Ioannis Ntanasis-Stathopoulos; Alexandros Briasoulis; Sentiljana Gumeni; Panagiotis Malandrakis; Despina Fotiou; Magdalini Migkou; Foteini Theodorakakou; Evangelos Eleutherakis-Papaiakovou; Nikolaos Kanellias; Efstathios Kastritis; Ioannis P Trougakos; Meletios A Dimopoulos
Journal:  Blood Adv       Date:  2021-11-09

Review 7.  BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.

Authors:  Marzia Palma; Tom A Mulder; Anders Österborg
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

Review 8.  Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.

Authors:  Dipti Talaulikar; Ranjana H Advani; Andrew R Branagan; Christian Buske; Meletios A Dimopoulos; Shirley D'Sa; Maria J Kersten; Veronique Leblond; Monique C Minnema; Roger G Owen; Maria Lia Palomba; Alessandra Tedeschi; Judith Trotman; Marzia Varettoni; Josephine M Vos; Steven P Treon; Efstathios Kastritis; Jorge J Castillo
Journal:  Hemasphere       Date:  2020-07-30

9.  Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence.

Authors:  Erica Chilson; Daniel A Scott; Beate Schmoele-Thoma; Wendy Watson; Mary M Moran; Raul Isturiz
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

Review 10.  Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

Authors:  Clare Sun; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2021-05-26       Impact factor: 2.861
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.